The round was co-led by prominent investors Columbus Venture Partners, Panakès Partners, and Mérieux Equity Partners. The financing round also had strong participation from existing investors Asabys...
La sepsis causa o contribuye directamente a 1 de cada 3 muertes hospitalarias en EE. UU., y el shock séptico tiene una tasa de mortalidad del 30-40% a nivel mundial. La dificultad para identificar in...
The funding from this new round is a crucial milestone for Deepull as it moves towards completing the clinical studies of its diagnostic system. The aim is to offer a transformative diagnostic solutio...
Through a co-investment loan of €200k, COFIDES will finance the consolidation of the aforementioned company's subsidiary in Mexico, operating since 2014 and focused on commercial activities and on c...
Las empresas navarras deben estar preparadas para el crecimiento exponencial del mercado de la biología sintética, capitalizar su potencial, identificando y evaluando el mercado y su atractivo y des...
ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced the successful closing of a $65 million Series A financing round. The...
Under the terms of the agreement, Merck assumes responsibility for the global development and commercialization of ApTOLL, with aptaTargets providing ongoing transitional support. The transaction incl...
España se sitúa como el cuarto país en inversión total en sanidad pública en Europa, con 134 mil millones de euros, superada solo por Alemania (489 mil millones), Francia (313 mil millones) e Ita...
The round was led by London-based VC Concentric, with participation from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg, known for backing 1...
The Series B financing was co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors: New Enterprise Associates, UCB ...
The round was led by Ship2B Ventures through its BSocial Impact Fund and Clave Capital, via its Clave Innohealth vehicle (supported by CDTI-Innvierte). Additional participants included Nara Capital, t...
The round, which also included participation from Roche Venture Fund and returning investors such as New Enterprise Associates, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis Venture Fund, an...